You must have one of these extentions in you browser
Title | Type | ![]() |
H index | Total Docs. (2014) | Total Docs. (3years) | Total Refs. (2014) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2014) | %Female (2014) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
180 | Sp2 | trade journal | 0.100 Q4 | 2 | 37 | 123 | 16 | 0 | 103 | 0.00 | 0.43 | 8.70 | ![]() |
179 | Chinese Journal of Cancer Biotherapy | journal | 0.101 Q4 | 5 | 102 | 232 | 2657 | 6 | 227 | 0.01 | 26.05 | 40.51 | ![]() |
178 | Cellular Therapy and Transplantation | journal | 0.102 Q4 | 8 | 0 | 10 | 0 | 1 | 10 | 0.00 | 0.00 | 0.00 | ![]() |
177 | Open Pharmacology Journal | journal | 0.104 Q4 | 6 | 0 | 10 | 0 | 1 | 9 | 0.11 | 0.00 | 0.00 | ![]() |
176 | Open Bioactive Compounds Journal | journal | 0.106 Q4 | 6 | 0 | 4 | 0 | 1 | 4 | 0.25 | 0.00 | 0.00 | ![]() |
175 | European Pharmaceutical Review | trade journal | 0.112 Q4 | 10 | 54 | 143 | 883 | 16 | 143 | 0.07 | 16.35 | 13.33 | ![]() |
174 | Gene Therapy and Molecular Biology | journal | 0.118 Q4 | 18 | 25 | 30 | 900 | 6 | 30 | 0.20 | 36.00 | 37.37 | ![]() |
173 | VacciMonitor![]() | journal | 0.120 Q4 | 6 | 19 | 46 | 341 | 11 | 44 | 0.24 | 17.95 | 57.14 | ![]() |
172 | Current Biomarkers | journal | 0.134 Q4 | 4 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | ![]() |
171 | IEEE International Conference on Nano/Molecular Medicine and Engineering, NANOMED | conference and proceedings | 0.134 | 6 | 0 | 58 | 0 | 8 | 54 | 0.14 | 0.00 | 0.00 | ![]() |
170 | Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry | journal | 0.148 Q4 | 17 | 48 | 148 | 1976 | 49 | 148 | 0.34 | 41.17 | 54.46 | ![]() |
169 | Drugs in Context![]() | journal | 0.161 Q4 | 40 | 7 | 16 | 361 | 15 | 14 | 0.94 | 51.57 | 30.43 | ![]() |
168 | Journal of Biological Sciences (discontinued) | journal | 0.167 Q4 | 40 | 62 | 225 | 2932 | 99 | 225 | 0.40 | 47.29 | 31.21 | ![]() |
167 | Methods in Pharmacology and Toxicology | book series | 0.167 Q4 | 15 | 88 | 44 | 4618 | 10 | 41 | 0.23 | 52.48 | 40.40 | ![]() |
166 | Profiles of Drug Substances, Excipients and Related Methodology | book series | 0.172 Q4 | 32 | 10 | 36 | 877 | 28 | 0 | 0.72 | 87.70 | 0.00 | ![]() |
165 | Pteridines![]() | journal | 0.174 Q4 | 19 | 9 | 53 | 297 | 20 | 52 | 0.24 | 33.00 | 47.37 | ![]() |
164 | Forum on Immunopathological Diseases and Therapeutics | journal | 0.175 Q4 | 15 | 23 | 79 | 1342 | 33 | 71 | 0.48 | 58.35 | 52.31 | ![]() |
163 | Nucleus (India) | journal | 0.181 Q4 | 19 | 27 | 56 | 824 | 27 | 55 | 0.50 | 30.52 | 32.65 | ![]() |
162 | Turkish Journal of Pharmaceutical Sciences![]() | journal | 0.188 Q4 | 26 | 39 | 100 | 1033 | 48 | 100 | 0.48 | 26.49 | 36.43 | ![]() |
161 | Current Cancer Therapy Reviews | journal | 0.200 Q4 | 19 | 29 | 93 | 1768 | 47 | 87 | 0.32 | 60.97 | 37.04 | ![]() |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2025. Data Source: Scopus®